Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

FM dyes effectively stain Merkel cells for long-term observation.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Systemic photodynamic therapy can effectively treat stubborn folliculitis decalvans with few side effects.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Red dots on the upper chest may be an early sign of certain types of hair loss.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

A 12-year-old girl's hair loss was linked to a rare genetic condition called ALX4-related frontonasal dysplasia.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Patients with Focal Dermal Hypoplasia often experience skin, nail, hair, and bone issues, and may benefit from calcium and vitamin D supplements.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

Some people with Frontal Fibrosing Alopecia may be allergic to a common sunscreen ingredient.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.